BFG Healthcare Marketing has helped French company Biosynex create ‘Amnioquick’, the first ever home test for Premature Rupture of Membranes (PROM).
Amnioquick is the world’s first home test that can check for leakage of amniotic fluid in pregnant women. The amniotic sac can sometimes develop a micro-rupture leading to leakage. This is known as premature rupture of membranes or PROM. PROM occurs in 6% to 19% of term pregnancies and is associated with 40% of preterm deliveries which can lead to significant morbidity and mortality.
BFG Healthcare Marketing has carried out all regulatory compliance issues for Biosynex, including the lay person testing and the work required to obtain CE mark registration for the product.
BFG has also designed the product’s packaging and created clear and easy to follow instructions for use.